Evaluation of digital construction, production and intraoral position accuracy of novel 3D CAD/CAM titanium retainers von Koller, S., Craveiro, R. B., Niederau, C., Pollak, T. L., Knaup, I., Wolf, M.

Volltext

Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B von Niederau, Christoph M, Niederau, Claus, Heintges, Tobias, Lange, Stefan, Goldmann, Georg, Mohr, Leonhard, Häussinger, Dieter

Volltext

Bessere Palliativbetreuung bei Lebezirrhose von Niederau, C.

Volltext

Real‐world use, effectiveness and safety of anti‐viral treatment in chronic hepatitis C genotype 3 infection von Cornberg, M., Petersen, J., Schober, A., Mauss, S., Böker, K. H. W., Link, R., Günther, R., Serfert, Y., Pfeiffer‐Vornkahl, H., Manns, M. P., Sarrazin, C., Hüppe, D., Berg, T., Niederau, C.

Volltext

Use of the 6 million viral load cut-off to guide treatment duration with ledipasvir/sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection: results from the Ger... von Vermehren, J, Athmann, C, Günther, R, Schott, E, Pathil, A, Boeker, K.H, Cornberg, M, Niederau, C, Simon, K.-G, Maasoumy, B, Sarrazin, C, Wedemeyer, H, Buggisch, P, C-Registry, G.H

Volltext

Long-term survival in patients with hereditary hemochromatosis von Niederau, C, Fischer, R, Purschel, A, Stremmel, W, Haussinger, D, Strohmeyer, G

Volltext

Treatment of HCV Genotype 2 with Sofosbuvir and Ribavirin Results in Low SVR Rates ina Real World Cohort (German Hepatitis C-Registry, DHC-R) von Tacke, F, Günther, R, Buggisch, P, Klinker, H, Schober, A, John, C, Lutz, T, Pfeiffer-Vornkahl, H, Niederau, C, Cornberg, M, Sarrazin, C, Mauss, S

Volltext

Resistance patterns in patients with chronic hepatitis C genotype 4 infection and treatment outcome von Dietz, J, Vermehren, J, Susser, S, Peiffer, K.-H, Grammatikos, G, Perner, D, Müllhaupt, B, Buggisch, P, Petersen, J, Schattenberg, J, Galle, P, Chave, J.-P, Kuhn, M, Zachoval, R, Niederau, C, Schulze zur Wiesch, J, Moreno, C, Berg, T, Berg, C, Zeuzem, S, Sarrazin, C

Volltext

Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R) von Cornberg, M, Buggisch, P, Schober, A, Schmutz, G, Böker, K.H.W, Link, R, Christensen, S, Büscher, K.-G, Pfeiffer-Vornkahl, H, Manns, M.P, Sarrazin, C, Hüppe, D, Berg, T, Niederau, C

Volltext

Ledipasvir/Sofosbuvir Treatment for 8 Weeks in Treatment-Naïve HCV Genotype 1 Infected Patients under Real Life Conditions: Data from the German Hepatitis C-Registry (DHC-R) von Buggisch, P, Böker, K.H.W, Günther, R, Teuber, G, Klinker, H, Pathil, A, Christensen, S, Peiffer-Vornkahl, H, Simon, K.-G, Niederau, C, Wedemeyer, H, Zeuzem, S

Volltext

Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial von Witthöft, Th, Möller, B., Wiedmann, K. H., Mauss, St, Link, R., Lohmeyer, J., Lafrenz, M., Gelbmann, C. M., Hüppe, D., Niederau, C., Alshuth, U.

Volltext

Boceprevir for Untreated Chronic HCV Genotype 1 Infection von Poordad, Fred, McCone, Jonathan, Bacon, Bruce R, Bruno, Savino, Manns, Michael P, Sulkowski, Mark S, Jacobson, Ira M, Reddy, K. Rajender, Goodman, Zachary D, Boparai, Navdeep, DiNubile, Mark J, Sniukiene, Vilma, Brass, Clifford A, Albrecht, Janice K, Bronowicki, Jean-Pierre

Volltext

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals von Dietz, Julia, Peiffer, Kai-Henrik, Hinrichsen, Holger, Buggisch, Peter, Felten, Gisela, Hüppe, Dietrich, Lutz, Thomas, Schott, Eckart, Berg, Christoph, Spengler, Ulrich, von Hahn, Thomas, Berg, Thomas, Vogelmann, R., Giostra, E., Berg, C., Wedemeyer, H., De Gottardi, A., Discher, T., Roeb, E., Wietzke-Braun, P., Herrmann, A., Kodal, A., Löbermann, M., Schulze zur Wiesch, J., Thimme, R., Schattenberg, J., Sprinzl, M., Schmidt, J., Schott, E., Siebler, J., Stauber, R., Schmiegel, W., Stremmel, W., Strey, B., Trautwein, C., Zachoval, R., Angeli, W., Gattringer, H., Genné, D., Hirschi, C., Kanzler, S., Kullig, U., Magenta, L., Menges, M., Niederau, C., Riecken, B., Roth, J., Schöfl, R., Schneider, A., Seelhoff, A., Semela, D., Walter, E., Winzer, T., Abels, W., Audebert, F., Barthel, K., Benninger, J., Bohr, U., Naumann, U., Bruch, H.R., Chirca, C., Dienethal, A., Dietel, P., Dreher, F., Emke, F., Fischer, J., Frederking, D., Frick, B., Goebel, F., Göbel, U., Herder, M., Heuer, S., Höffl, K.H., Hofmann, W.P., John, C., Kallinowski, B., Khaykin, P., Köster, A., Künzig, B., Littman, M., Löhr, H., Lutz, U., Maurer, P., Moritzen, D., Mroß, M., Mundlos, M., Ningel, K., Oelmann, A., Pascher, E., Philipp, A., Rietzler, S., Schmidt, W., Schwenzer, J., Simon, K., Steffens, H., Tacke, W., Thieringer, J., Ullrich, J., Werheid-Dobers, M., Zipf, A.

Volltext

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection von Bacon, Bruce R, Gordon, Stuart C, Lawitz, Eric, Marcellin, Patrick, Vierling, John M, Zeuzem, Stefan, Poordad, Fred, Goodman, Zachary D, Sings, Heather L, Boparai, Navdeep, Burroughs, Margaret, Brass, Clifford A, Albrecht, Janice K, Esteban, Rafael

Volltext

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT... von Kwo, Paul Y, Dr, Lawitz, Eric J, MD, McCone, Jonathan, MD, Schiff, Eugene R, Prof, Vierling, John M, Prof, Pound, David, MD, Davis, Mitchell N, DO, Galati, Joseph S, MD, Gordon, Stuart C, MD, Ravendhran, Natarajan, MD, Rossaro, Lorenzo, Prof, Anderson, Frank H, MD, Jacobson, Ira M, Prof, Rubin, Raymond, MD, Koury, Kenneth, PhD, Pedicone, Lisa D, PhD, Brass, Clifford A, MD, Chaudhri, Eirum, MD, Albrecht, Janice K, PhD

Volltext

54 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS von Pietrangelo, A, Brissot, P, Bonkovsky, H, Niederau, C, Rojkjaer, L, Weitzman, R, Williamson, P, Schoenborn-Kellenberger, O, Phatak, P

Volltext

187 A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE -RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS von Phatak, P, Brissot, P, Wurster, M, Adams, P.C, Bonkovsky, H.L, Gross, J, Malfertheiner, P, McLaren, G.D, Niederau, C, Piperno, A, Powell, L.W, Russo, M, Stoelzel, U, Stremmel, W, Griffel, L, Lynch, N, Zhang, Y, Pietrangelo, A

Volltext

49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE... von Bruix, J, Poynard, T, Colombo, M, Schiff, E, Reichen, J, Burak, K, Heathcote, E.J.L, Berg, T, Poo-Ramirez, J.-L, Mello, C. Brandao, Guenther, R, Niederau, C, Terg, R, Bopari, N, Harvey, J, Griffel, L.H, Burroughs, M, Brass, C.A, Albrecht, J.K

Volltext

Hepatitis C: Patienteninformation von Niederau, C.

Volltext

Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results von Poll, L W, Koch, J A, vom Dahl, S, Willers, R, Scherer, A, Boerner, D, Niederau, C, Häussinger, D, Mödder, U

Volltext